JA2-WP5

Home  /  Outputs   /  JA2-WP5

This document is the Procedure Manual for Rapid Relative Effectiveness Assessments of other health technologies such as medical devices, surgical interventions or diagnostics, produced by EUnetHTA JA2 WP5 Strand B. This Manual guides the production of rapid assessments of

The purpose of the assessment is to address the research question whether the use of the technologies in question is more effective and/or safer than their comparators, which were chosen based on CE mark indications, recommendations in clinical guidelines for

The purpose of the assessment is to evaluate Vorapaxar (ZONTIVITY™) for the reduction of cardiovascular events. Final version of the assessment was published in June 2015 Below is the documentation provided by the Joint Assessment authoring team Vorapaxar for the reduction of thrombotic